← Back to ATC View

L01XC - Monoclonal antibodies

Substances (38)

L01XC01 - edrecolomab

L01XC02 - rituximab

L01XC03 - trastuzumab

L01XC05 - gemtuzumab ozogamicin

L01XC06 - cetuximab

L01XC07 - bevacizumab

L01XC08 - panitumumab

L01XC09 - catumaxomab

L01XC10 - ofatumumab

L01XC11 - ipilimumab

L01XC12 - brentuximab vedotin

L01XC13 - pertuzumab

L01XC14 - trastuzumab emtansine

L01XC15 - obinutuzumab

L01XC16 - dinutuximab beta

L01XC17 - nivolumab

L01XC18 - pembrolizumab

L01XC19 - blinatumomab

L01XC21 - ramucirumab

L01XC22 - necitumumab

L01XC23 - elotuzumab

L01XC24 - daratumumab

L01XC25 - mogamulizumab

L01XC26 - inotuzumab ozogamicin

L01XC27 - olaratumab

L01XC28 - durvalumab

L01XC29 - bermekimab

L01XC31 - avelumab

L01XC32 - atezolizumab

L01XC33 - cemiplimab

L01XC34 - moxetumomab pasudotox

L01XC35 - tafasitamab

L01XC36 - enfortumab vedotin

L01XC37 - polatuzumab vedotin

L01XC38 - isatuximab

L01XC39 - belantamab mafodotin

L01XC40 - dostarlimab

L01XC41 - trastuzumab deruxtecan